SARS-CoV-2 Omicron variant escapes neutralization by vaccinated and convalescent sera and therapeutic monoclonal antibodies

Nariko Ikemura, Atsushi Hoshino, Yusuke Higuchi, Shunta Taminishi, Tohru Inaba, Satoaki Matoba
doi: https://doi.org/10.1101/2021.12.13.21267761

Article Information

doi 
https://doi.org/10.1101/2021.12.13.21267761
History 
  • December 14, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Nariko Ikemura1,
  2. Atsushi Hoshino1,*,
  3. Yusuke Higuchi1,
  4. Shunta Taminishi1,
  5. Tohru Inaba2 and
  6. Satoaki Matoba1
  1. 1Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
  2. 2Department of Infection Control and Laboratory Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
  1. ↵*Correspondence: a-hoshi{at}koto.kpu-m.ac.jp (A.H.),
Back to top
Posted December 14, 2021.
Download PDF
Data/Code
Email
SARS-CoV-2 Omicron variant escapes neutralization by vaccinated and convalescent sera and therapeutic monoclonal antibodies
Nariko Ikemura, Atsushi Hoshino, Yusuke Higuchi, Shunta Taminishi, Tohru Inaba, Satoaki Matoba
medRxiv 2021.12.13.21267761; doi: https://doi.org/10.1101/2021.12.13.21267761
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area